We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company noted that the performance of all rapid antigen tests has come under scrutiny in light of the large number of mutations in the Omicron variant. Read More
Alpha Tau Medical said its alpha-radiation cancer therapy device Alpha DaRT produced complete tumor responses in all 10 patients treated in a multi-center U.S. trial. Read More
Ophthalmic device company Alcon has completed its $475 million purchase of Ivantis, developer of the Hydrus Microstent, a glaucoma surgery device used to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery. Read More
T-cell response to the virus declines more slowly than antibody responses and may indicate how severe the course of COVID-19 will be in infected patients. Read More